| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/06/2008 | US20080275029 Compounds for Treating Protein-Kinase Mediated Disorders |
| 11/06/2008 | US20080275025 Substituted Lactams and Their Use as Anti-Cancer Agents |
| 11/06/2008 | US20080275022 Substituted Quinazolones as Anti-Cancer Agents |
| 11/06/2008 | US20080275019 Metal complex protein kinase inhibitors |
| 11/06/2008 | US20080275017 Aromatic sulfenates for type i phototherapy |
| 11/06/2008 | US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed |
| 11/06/2008 | US20080275009 Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof |
| 11/06/2008 | US20080275005 Mitochondrially targeted antioxidants |
| 11/06/2008 | US20080275002 Method for Treatment of Hepatic Cancer |
| 11/06/2008 | US20080274998 Adjust biological activity of moesin by binding; parasiticides; bactericides; central nervous system disorders; Down's syndrome; antiinflamamtory agents; anticancer agents; autoimmune diseases; skin disorders; gastrointestinal disorders |
| 11/06/2008 | US20080274996 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin |
| 11/06/2008 | US20080274995 Suppression of Nuclear Factor-KappaB Dependent Processes Using Oligonucleotides |
| 11/06/2008 | US20080274987 Novel alpha glucosidase activator, pulicarside 1 |
| 11/06/2008 | US20080274970 Vascular adhesion molecules and modulation of their function |
| 11/06/2008 | US20080274968 In vitro methods for detecting renal cancer |
| 11/06/2008 | US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof |
| 11/06/2008 | US20080274961 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activated peptide |
| 11/06/2008 | US20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster |
| 11/06/2008 | US20080274956 Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein |
| 11/06/2008 | US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer |
| 11/06/2008 | US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells |
| 11/06/2008 | US20080274475 Hla-e binding |
| 11/06/2008 | US20080274468 Novel means for the diagnosis and therapy of ctcl |
| 11/06/2008 | US20080274197 Lyophilized formulation |
| 11/06/2008 | US20080274192 Pharmaceutical Compositions Comprising an Amorphous Form of a Vegf-R-Inhibitor |
| 11/06/2008 | US20080274173 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 11/06/2008 | US20080274133 Soluble Bifunctional Proteins |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274120 Antiproliferative agents; kits; antibodies against VEGF, an antibody against CD20, rituximab, bortezomib, thalidomide, dexamethasone, vincristine, doxorubicin, and melphalan |
| 11/06/2008 | US20080274119 Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration |
| 11/06/2008 | US20080274116 Lipids, Lipid Complexes and Use Thereof |
| 11/06/2008 | US20080274115 Human estrogen specific immunoglobulin for use as evaluative tool in diagnosing/prognosing metastatic cancers; evaluating efficacy of anticancer treatment |
| 11/06/2008 | US20080274114 Anti-Egfr Antibodies |
| 11/06/2008 | US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury |
| 11/06/2008 | US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders |
| 11/06/2008 | US20080274108 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274106 Using interleukin-6 specific monoclonal antibody as therapeutic in treatment and prevention of lung cancer |
| 11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274104 Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics |
| 11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/06/2008 | US20080274092 Erythrocytes Containing Arginine Deiminase |
| 11/06/2008 | US20080274086 Use of Cxcr4 Protein Expression on the Surface of Stem Cells as a Marker for Tumor Tropic Potential |
| 11/06/2008 | US20080274085 Nutrient broth comprising bifidobacterium for use as therapeutic in treatment of gastrointestinal disorders |
| 11/06/2008 | US20080274078 Novel uses |
| 11/06/2008 | US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells |
| 11/06/2008 | US20080274049 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | DE4232465B4 Arzneimittel oder diätetische Lebensmittel, ihre Verwendung und Verfahren zu deren Herstellung Drug or dietary foods, their use and processes for their preparation |
| 11/06/2008 | CA2687943A1 N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions |
| 11/06/2008 | CA2685739A1 Hydroxy sulfonate of quinone compounds and their uses |
| 11/06/2008 | CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 11/06/2008 | CA2685124A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | CA2685106A1 6-phenylpyrimidinones as pim modulators |
| 11/06/2008 | CA2685099A1 Antibodies against ramp3 |
| 11/06/2008 | CA2684968A1 Compounds, compositions containing such compounds, and methods of treatment of cancer and autoimmune diseases using such compounds |
| 11/06/2008 | CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 11/06/2008 | CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | CA2679658A1 Fusion proteins binding to growth factors |
| 11/06/2008 | CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 11/05/2008 | EP1988171A1 Substance fki-2342 and process for production thereof |
| 11/05/2008 | EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 11/05/2008 | EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1988089A1 Imatinib base, and imatinib mesylate and processes for preparation thereof |
| 11/05/2008 | EP1988081A1 Binding inhibitor of sphingosine-1-phosphate |
| 11/05/2008 | EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor. |
| 11/05/2008 | EP1987842A1 Cell proliferation inhibitor |
| 11/05/2008 | EP1987838A1 Novel compound for treatment of tumor |
| 11/05/2008 | EP1987138A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 11/05/2008 | EP1987037A2 Fused heterocyclic compound |
| 11/05/2008 | EP1987028A2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 11/05/2008 | EP1987024A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 11/05/2008 | EP1987023A1 Hydrate forms of amg706 |
| 11/05/2008 | EP1986687A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 11/05/2008 | EP1986678A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 11/05/2008 | EP1986667A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 11/05/2008 | EP1986664A1 Composition for treating cancer comprising oligonucleotide and non-toxic lps |
| 11/05/2008 | EP1986660A2 Hexose compounds to treat cancer |
| 11/05/2008 | EP1986658A2 Ibandronate new regimen for treating metastatic bone pain |
| 11/05/2008 | EP1986656A2 Withacnistin compounds for treatment of cancer |
| 11/05/2008 | EP1986648A2 Hydroxylamines and derivatives as anti-angiogenic agents |
| 11/05/2008 | EP1986635A2 Anticancer agents |
| 11/05/2008 | EP1986632A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic |
| 11/05/2008 | EP1986630A2 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy |
| 11/05/2008 | EP1986625A1 Treatment of ovarian cancer |
| 11/05/2008 | EP1986619A2 Use of phosphatases to treat tumors overexpressing n-cor |
| 11/05/2008 | EP1986610A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
| 11/05/2008 | EP1761515B1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 11/05/2008 | EP1664032B1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors |
| 11/05/2008 | EP1608663B1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof |
| 11/05/2008 | EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/05/2008 | EP1465996B1 Raf/ras binding compounds |
| 11/05/2008 | EP1465876B1 Long chain fatty alcohol substituents in antineoplastic agents |
| 11/05/2008 | EP1448215B1 Use of laminarin in the treatment of cancer |
| 11/05/2008 | EP1372671B1 Methylation modulating agents for intraductal treatment of breast cancer |
| 11/05/2008 | EP1355634B1 Sn-38 lipid complexes and methods of use |
| 11/05/2008 | EP1341811B9 Orally ingestible preparation of mistletoe lectins and method |
| 11/05/2008 | EP1324970B1 Retinoids for the treatment of emphysema |